{
    "info": {
        "nct_id": "NCT03011372",
        "official_title": "A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)",
        "inclusion_criteria": "* Documented lymphoid or myeloid neoplasm with 8p11 rearrangement known to lead to FGFR1 activation, based on standard diagnostic cytogenetic evaluation performed locally, before signing informed consent for this study.\n* Eligible subjects must:\n\n  * Have relapsed after stem cell transplantation or after other disease modifying therapy, OR\n  * Not be current candidates for stem cell transplantation or other disease modifying therapies.\n* Note: All relapsed/refractory subjects must have evidence of either cytogenetic or hematological disease and have no evidence of residual toxicity (eg, graft-versus-host disease requiring treatment).\n* Life expectancy ≥ 12 weeks.\n* Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Prior receipt of a selective FGFR inhibitor.\n* History and/or current evidence of ectopic mineralization/calcification, including but not limited to soft tissue, kidneys, intestine, myocardia, or lung, except calcified lymph nodes and asymptomatic arterial or cartilage/tendon calcifications.\n* Current evidence of corneal disorder/keratopathy, including but not limited to bullous/band keratopathy, corneal abrasion, inflammation/ulceration, and keratoconjunctivitis, as confirmed by ophthalmologic examination.\n* Use of any potent cytochrome P450 3A4 inhibitors or inducers within 14 days or 5 half-lives (whichever is shorter) before the first dose of study drug.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Eligible subjects must:",
                "criterions": []
            },
            "logical_structure": {
                "and_criteria": []
            }
        },
        {
            "identified_line": {
                "line": "* Documented lymphoid or myeloid neoplasm with 8p11 rearrangement known to lead to FGFR1 activation, based on standard diagnostic cytogenetic evaluation performed locally, before signing informed consent for this study.",
                "criterions": [
                    {
                        "exact_snippets": "Documented lymphoid or myeloid neoplasm",
                        "criterion": "lymphoid or myeloid neoplasm",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Documented lymphoid or myeloid neoplasm",
                        "criterion": "lymphoid or myeloid neoplasm",
                        "requirement": {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "8p11 rearrangement known to lead to FGFR1 activation",
                        "criterion": "8p11 rearrangement leading to FGFR1 activation",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "based on standard diagnostic cytogenetic evaluation performed locally",
                        "criterion": "diagnostic cytogenetic evaluation",
                        "requirement": {
                            "requirement_type": "method",
                            "expected_value": "standard diagnostic cytogenetic evaluation performed locally"
                        }
                    },
                    {
                        "exact_snippets": "before signing informed consent for this study",
                        "criterion": "timing of diagnostic evaluation",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "before signing informed consent"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Documented lymphoid or myeloid neoplasm",
                        "criterion": "lymphoid or myeloid neoplasm",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Documented lymphoid or myeloid neoplasm",
                        "criterion": "lymphoid or myeloid neoplasm",
                        "requirement": {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "8p11 rearrangement known to lead to FGFR1 activation",
                        "criterion": "8p11 rearrangement leading to FGFR1 activation",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "based on standard diagnostic cytogenetic evaluation performed locally",
                        "criterion": "diagnostic cytogenetic evaluation",
                        "requirement": {
                            "requirement_type": "method",
                            "expected_value": "standard diagnostic cytogenetic evaluation performed locally"
                        }
                    },
                    {
                        "exact_snippets": "before signing informed consent for this study",
                        "criterion": "timing of diagnostic evaluation",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "before signing informed consent"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2.",
                "criterions": [
                    {
                        "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Have relapsed after stem cell transplantation or after other disease modifying therapy, OR",
                "criterions": [
                    {
                        "exact_snippets": "Have relapsed after stem cell transplantation",
                        "criterion": "relapse after stem cell transplantation",
                        "requirement": {
                            "requirement_type": "history of relapse",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Have relapsed after stem cell transplantation",
                        "criterion": "relapse after stem cell transplantation",
                        "requirement": {
                            "requirement_type": "prior treatment",
                            "expected_value": "stem cell transplantation"
                        }
                    },
                    {
                        "exact_snippets": "relapsed ... after other disease modifying therapy",
                        "criterion": "relapse after other disease modifying therapy",
                        "requirement": {
                            "requirement_type": "history of relapse",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "relapsed ... after other disease modifying therapy",
                        "criterion": "relapse after other disease modifying therapy",
                        "requirement": {
                            "requirement_type": "prior treatment",
                            "expected_value": "other disease modifying therapy"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Have relapsed after stem cell transplantation",
                                "criterion": "relapse after stem cell transplantation",
                                "requirement": {
                                    "requirement_type": "history of relapse",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Have relapsed after stem cell transplantation",
                                "criterion": "relapse after stem cell transplantation",
                                "requirement": {
                                    "requirement_type": "prior treatment",
                                    "expected_value": "stem cell transplantation"
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "relapsed ... after other disease modifying therapy",
                                "criterion": "relapse after other disease modifying therapy",
                                "requirement": {
                                    "requirement_type": "history of relapse",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "relapsed ... after other disease modifying therapy",
                                "criterion": "relapse after other disease modifying therapy",
                                "requirement": {
                                    "requirement_type": "prior treatment",
                                    "expected_value": "other disease modifying therapy"
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Note: All relapsed/refractory subjects must have evidence of either cytogenetic or hematological disease and have no evidence of residual toxicity (eg, graft-versus-host disease requiring treatment).",
                "criterions": [
                    {
                        "exact_snippets": "All relapsed/refractory subjects must have evidence of either cytogenetic or hematological disease",
                        "criterion": "cytogenetic or hematological disease",
                        "requirement": {
                            "requirement_type": "evidence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "no evidence of residual toxicity (eg, graft-versus-host disease requiring treatment)",
                        "criterion": "residual toxicity",
                        "requirement": {
                            "requirement_type": "evidence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "graft-versus-host disease requiring treatment",
                        "criterion": "graft-versus-host disease requiring treatment",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "condition": {
                    "exact_snippets": "All relapsed/refractory subjects must have evidence of either cytogenetic or hematological disease",
                    "criterion": "cytogenetic or hematological disease",
                    "requirement": {
                        "requirement_type": "evidence",
                        "expected_value": true
                    }
                },
                "then_criteria": {
                    "and_criteria": [
                        {
                            "exact_snippets": "no evidence of residual toxicity (eg, graft-versus-host disease requiring treatment)",
                            "criterion": "residual toxicity",
                            "requirement": {
                                "requirement_type": "evidence",
                                "expected_value": false
                            }
                        },
                        {
                            "exact_snippets": "graft-versus-host disease requiring treatment",
                            "criterion": "graft-versus-host disease requiring treatment",
                            "requirement": {
                                "requirement_type": "presence",
                                "expected_value": false
                            }
                        }
                    ]
                },
                "else_criteria": null
            }
        },
        {
            "identified_line": {
                "line": "* Life expectancy ≥ 12 weeks.",
                "criterions": [
                    {
                        "exact_snippets": "Life expectancy ≥ 12 weeks.",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "weeks"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Life expectancy ≥ 12 weeks.",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "weeks"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Not be current candidates for stem cell transplantation or other disease modifying therapies.",
                "criterions": [
                    {
                        "exact_snippets": "Not be current candidates for stem cell transplantation",
                        "criterion": "stem cell transplantation candidacy",
                        "requirement": {
                            "requirement_type": "current candidacy",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Not be current candidates for ... other disease modifying therapies",
                        "criterion": "disease modifying therapy candidacy",
                        "requirement": {
                            "requirement_type": "current candidacy",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Not be current candidates for stem cell transplantation",
                        "criterion": "stem cell transplantation candidacy",
                        "requirement": {
                            "requirement_type": "current candidacy",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Not be current candidates for ... other disease modifying therapies",
                        "criterion": "disease modifying therapy candidacy",
                        "requirement": {
                            "requirement_type": "current candidacy",
                            "expected_value": false
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "* Prior receipt of a selective FGFR inhibitor.",
                "criterions": [
                    {
                        "exact_snippets": "Prior receipt of a selective FGFR inhibitor.",
                        "criterion": "prior receipt of selective FGFR inhibitor",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Prior receipt of a selective FGFR inhibitor.",
                    "criterion": "prior receipt of selective FGFR inhibitor",
                    "requirement": {
                        "requirement_type": "history of treatment",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "* Current evidence of corneal disorder/keratopathy, including but not limited to bullous/band keratopathy, corneal abrasion, inflammation/ulceration, and keratoconjunctivitis, as confirmed by ophthalmologic examination.",
                "criterions": [
                    {
                        "exact_snippets": "Current evidence of corneal disorder/keratopathy",
                        "criterion": "corneal disorder/keratopathy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Current evidence of corneal disorder/keratopathy",
                        "criterion": "corneal disorder/keratopathy",
                        "requirement": {
                            "requirement_type": "current",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "bullous/band keratopathy",
                        "criterion": "bullous keratopathy or band keratopathy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "corneal abrasion",
                        "criterion": "corneal abrasion",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "inflammation/ulceration",
                        "criterion": "corneal inflammation or ulceration",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "keratoconjunctivitis",
                        "criterion": "keratoconjunctivitis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "as confirmed by ophthalmologic examination",
                        "criterion": "ophthalmologic examination confirmation",
                        "requirement": {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "and_criteria": [
                                    {
                                        "and_criteria": [
                                            {
                                                "and_criteria": [
                                                    {
                                                        "and_criteria": [
                                                            {
                                                                "and_criteria": [
                                                                    {
                                                                        "exact_snippets": "Current evidence of corneal disorder/keratopathy",
                                                                        "criterion": "corneal disorder/keratopathy",
                                                                        "requirement": {
                                                                            "requirement_type": "presence",
                                                                            "expected_value": true
                                                                        }
                                                                    },
                                                                    {
                                                                        "exact_snippets": "Current evidence of corneal disorder/keratopathy",
                                                                        "criterion": "corneal disorder/keratopathy",
                                                                        "requirement": {
                                                                            "requirement_type": "current",
                                                                            "expected_value": true
                                                                        }
                                                                    }
                                                                ]
                                                            },
                                                            {
                                                                "exact_snippets": "as confirmed by ophthalmologic examination",
                                                                "criterion": "ophthalmologic examination confirmation",
                                                                "requirement": {
                                                                    "requirement_type": "confirmation",
                                                                    "expected_value": true
                                                                }
                                                            }
                                                        ]
                                                    },
                                                    {
                                                        "or_criteria": [
                                                            {
                                                                "exact_snippets": "bullous/band keratopathy",
                                                                "criterion": "bullous keratopathy or band keratopathy",
                                                                "requirement": {
                                                                    "requirement_type": "presence",
                                                                    "expected_value": true
                                                                }
                                                            },
                                                            {
                                                                "exact_snippets": "corneal abrasion",
                                                                "criterion": "corneal abrasion",
                                                                "requirement": {
                                                                    "requirement_type": "presence",
                                                                    "expected_value": true
                                                                }
                                                            },
                                                            {
                                                                "exact_snippets": "inflammation/ulceration",
                                                                "criterion": "corneal inflammation or ulceration",
                                                                "requirement": {
                                                                    "requirement_type": "presence",
                                                                    "expected_value": true
                                                                }
                                                            },
                                                            {
                                                                "exact_snippets": "keratoconjunctivitis",
                                                                "criterion": "keratoconjunctivitis",
                                                                "requirement": {
                                                                    "requirement_type": "presence",
                                                                    "expected_value": true
                                                                }
                                                            }
                                                        ]
                                                    }
                                                ]
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "exact_snippets": "as confirmed by ophthalmologic examination",
                        "criterion": "ophthalmologic examination confirmation",
                        "requirement": {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        }
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "* Use of any potent cytochrome P450 3A4 inhibitors or inducers within 14 days or 5 half-lives (whichever is shorter) before the first dose of study drug.",
                "criterions": [
                    {
                        "exact_snippets": "Use of any potent cytochrome P450 3A4 inhibitors ... within 14 days or 5 half-lives (whichever is shorter) before the first dose of study drug.",
                        "criterion": "use of potent cytochrome P450 3A4 inhibitors",
                        "requirement": {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 14,
                                        "unit": "days"
                                    },
                                    {
                                        "operator": ">",
                                        "value": 5,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "Use of any potent cytochrome P450 3A4 ... inducers within 14 days or 5 half-lives (whichever is shorter) before the first dose of study drug.",
                        "criterion": "use of potent cytochrome P450 3A4 inducers",
                        "requirement": {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 14,
                                        "unit": "days"
                                    },
                                    {
                                        "operator": ">",
                                        "value": 5,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Use of any potent cytochrome P450 3A4 inhibitors ... within 14 days or 5 half-lives (whichever is shorter) before the first dose of study drug.",
                        "criterion": "use of potent cytochrome P450 3A4 inhibitors",
                        "requirement": {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 14,
                                        "unit": "days"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "Use of any potent cytochrome P450 3A4 ... inducers within 14 days or 5 half-lives (whichever is shorter) before the first dose of study drug.",
                        "criterion": "use of potent cytochrome P450 3A4 inducers",
                        "requirement": {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 14,
                                        "unit": "days"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* History and/or current evidence of ectopic mineralization/calcification, including but not limited to soft tissue, kidneys, intestine, myocardia, or lung, except calcified lymph nodes and asymptomatic arterial or cartilage/tendon calcifications.",
                "criterions": [
                    {
                        "exact_snippets": "History and/or current evidence of ectopic mineralization/calcification",
                        "criterion": "ectopic mineralization/calcification",
                        "requirement": {
                            "requirement_type": "history or current evidence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "including but not limited to soft tissue, kidneys, intestine, myocardia, or lung",
                        "criterion": "ectopic mineralization/calcification in specific organs",
                        "requirement": {
                            "requirement_type": "location",
                            "expected_value": [
                                "soft tissue",
                                "kidneys",
                                "intestine",
                                "myocardia",
                                "lung"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "except calcified lymph nodes and asymptomatic arterial or cartilage/tendon calcifications",
                        "criterion": "calcified lymph nodes and asymptomatic arterial or cartilage/tendon calcifications",
                        "requirement": {
                            "requirement_type": "exclusion",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_miscellaneous": []
}